Oral solids
ROIS is an FDA-approved oral solid dose manufacturing partner, producing up to three billion tablets and 30 million sachets annually for distribution across 45 markets.
3 billion
4
30 million annually
Aluminium and PVC
Commercial-scale oral solid dose, end to end.
ROIS oral solid dose manufacturing encompasses wet and high-shear granulation, ribbon blending, roller compaction, tablet compression, bilayer tableting and film coating.
Six high-speed tablet presses support output of up to 520,000 tablets per hour. Packaging capability includes four blister lines supporting aluminum and PVC formats, two sachet lines for both tablet and powder presentations and integrated serialization and aggregation.
Commercial scale
Manufacturing flexibility
High-speed production
FAQs
ROIS provides large-scale commercial manufacturing for tablets and sachets, with annual capacity exceeding three billion tablets and 30 million sachets. Flexible manufacturing technologies support a broad range of product and production requirements.
ROIS capabilities include wet granulation, high-shear granulation, ribbon blending, roller compaction, tablet compression and film coating, providing multiple manufacturing routes to support different formulation and commercial production requirements.
Yes. Six high-speed tablet presses provide production speeds ranging from 100,000 to 520,000 tablets per hour, backed by annual manufacturing capacity exceeding three billion tablets for large-scale commercial pharmaceutical supply.
Yes. Experienced technical and manufacturing teams can support the transfer of established oral solid dose products into ROIS manufacturing operations, aligning process requirements, equipment, quality systems and commercial production needs to establish reliable long-term supply.
Explore further
Sterile manufacturing
Cytotoxic and lyophilization
Drug substance
Locations
News and resources
Personalized partnerships. Global reach.
Connect with the ROIS team to explore how this capability can support the next program.